Jennifer Baynosa, MD
Surgical Oncology · Las Vegas, NVNPI 1184748212
Payments from drug & device makers
Across 108 payments — averaging $102.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- TELA Bio, Inc.$2K
- Axogen$2K
- Davol Inc.$689
- Bard Peripheral Vascular, Inc.$485
- Intuitive Surgical$416
- plus $2K from 19 others
What the payments were for
- Travel & lodging$8688%
- Food & beverage$10,21092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $2,943 |
| TELA Bio, Inc. | 16 | $2,236 |
| Axogen | 13 | $1,819 |
| Davol Inc. | 5 | $689 |
| Bard Peripheral Vascular, Inc. | 1 | $485 |
| Intuitive Surgical | 4 | $416 |
| Mentor Worldwide LLC | 6 | $353 |
| Motiva USA, LLC | 3 | $344 |
| RTI Surgical, Inc | 2 | $285 |
| Dilon Technologies, Inc. | 1 | $178 |
| Innovation Technologies Inc | 2 | $174 |
| Medtronic | 4 | $164 |
| Foundation Medicine, Inc. | 1 | $148 |
| Stryker | 1 | $138 |
| Mallinckrodt Hospital Products Inc. | 1 | $117 |
| Integra Lifesciences Corporation | 1 | $117 |
| Merck | 1 | $102 |
| Tactile Systems Technology Inc | 6 | $96 |
| KCI USA, Inc. | 1 | $83 |
| Sientra, Inc. | 1 | $72 |
| Kls-martin L.p. | 1 | $28 |
| Smith+Nephew | 1 | $27 |
| Acera Surgical, Inc. | 1 | $23 |
| BD | 1 | $22 |
| Organogenesis Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$1,554
- AxoGuard Nerve Connector$1,451
- AxoGuard Nerve Protector$1,451
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,130
- OviTex 2S$907
- NATRELLE SALINE-FILLED BREAST IMPLANTS$872
- Phasix Mesh$630
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$519
- GalaFLEX$485
- ALLODERM$402
- Motiva Implant Matrix$322
- NATRELLE$253
- Da Vinci Surgical System$224
- AXOGUARD HA+ NERVE PROTECTOR$206
- AxoGuard Nerve Cap$206
- HemoBlast Bellows$178
- Irrisept$152
- FOUNDATIONONE$148
- FOUNDATIONONE HEME$148
- FOUNDATIONONE CDX$148
How this compares
Too few surgical oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 16 | $36 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Las Vegas
- Saju JosephLas Vegas$182K
- Charles St HillLas Vegas$12K
- Matthew SelleckLas Vegas$12K
- Lorena Suarez-KellyLas Vegas$4K
- Daniel KirganLas Vegas$1K
- Kara BowersNellis Afb$740
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.